Non-cross resistance of ZD0473 in acquired cisplatin-resistant lung cancer cell lines
- 1 October 2002
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 38 (1) , 43-50
- https://doi.org/10.1016/s0169-5002(02)00175-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cellular and molecular determinants of cisplatin resistanceEuropean Journal Of Cancer, 1998
- Circumvention of glutathione-mediated mitomycin C resistance by a novel mitomycin C analogue, KW-2149International Journal of Cancer, 1997
- γ-Glutamylcysteine Synthetase Gene Overexpression Results in Increased Activity of the ATP-Dependent Glutathione S-Conjugate Export Pump and Cisplatin ResistanceBiochemical and Biophysical Research Communications, 1995
- Ouabain‐resistant non‐small‐cell lung‐cancer CELL LINE SHOWS COLLATERAL SENSITIVITY TO cis‐diamminedichloroplatinum(II) (CDDP)International Journal of Cancer, 1994
- The Mechanism of the Difference in Cellular Uptake of Platinum Derivatives in Non‐small Cell Lung Cancer Cell Line (PC‐14) and Its Cisplatin‐resistant Subline (PC‐14/CDDP)Japanese Journal of Cancer Research, 1993
- Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acidBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
- Modulation of cis‐diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3‐isobutyl‐1‐methylxanthine in sensitive and resistant human ovarian carcinoma cellsInternational Journal of Cancer, 1991
- Reversal of Cisplatin Resistance with Amphotericin B in a Non‐small Cell Lung Cancer Cell LineJapanese Journal of Cancer Research, 1991
- Establishment and characterization of cisplatin‐resistant sublines of human lung cancer cell linesInternational Journal of Cancer, 1988
- Preclinical studies identifying carboplatin as a viable cisplatin alternativeCancer Treatment Reviews, 1985